Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Sanofi said to be near $11.5 billion deal to buy Bioverativ By: MarketWatch January 21, 2018 at 20:54 PM EST Sanofi SA is nearing a deal to buy hemophilia drugmaker Bioverativ Inc. for more than $11.5 billion as the French drugmaker looks set to clinch a big deal while it braces for generic competition for its top-selling product. Read More >> Related Stocks: Sanofi-Aventis S.A. ADR Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Sanofi said to be near $11.5 billion deal to buy Bioverativ By: MarketWatch January 21, 2018 at 20:54 PM EST Sanofi SA is nearing a deal to buy hemophilia drugmaker Bioverativ Inc. for more than $11.5 billion as the French drugmaker looks set to clinch a big deal while it braces for generic competition for its top-selling product. Read More >> Related Stocks: Sanofi-Aventis S.A. ADR